Symptom distress in advanced cancer patients with anxiety and depression in the palliative care setting

Delgado-Guay, Marvin Omar; Parsons, Henrique A.; Li, Zhijun; Palmer, J. Lynn; Bruera, Éduardo

doi:10.1007/s00520-008-0529-7

Cited by 219 publications

(199 citation statements)

References 44 publications

Supporting

Mentioning

170

Contrasting

Unclassified

Order By: Relevance

“…As indicated by previous research in western settings, patients rarely express psychological distress and concerns directly (Uitterhoeve et al, 2009;Delgado-Guay et al, 2009;Heyn et al, 2012). It may be possible that the more frequent expression of multiple symptoms could perhaps indicate a latent expression of psychological distress.…”

Section: Discussionmentioning

confidence: 86%

Symptom Prevalence and Related Distress in Cancer Patients Undergoing Chemotherapy

Thiagarajan

Chan²,

et al. 2016

Asian Pacific Journal of Cancer Prevention

View full text Add to dashboard Cite

Background: Much has been done to examine the psychological impact of cancer treatment, but it remains unclear to what extent anxiety and depression is related to symptom prevalence. The present study concerned the characteristics and frequency of distress as related to symptom prevalence in cancer patients undergoing chemotherapy in Malaysia. Materials and Methods: Participants were 303 consecutive adult cancer patients undergoing chemotherapy in an academic medical center. The short form Memorial Symptom Assessment Scale (MSAS-SF), which covers three domains of symptoms (global distress, physical-and psychological symptoms) was used to cross-sectionally measure symptom frequency and associated distress via self-reporting. One-way ANOVA and t-tests were used to test mean differences among MSAS-SF subscale scores. Results: Complete data were available for 303 patients. The mean number of symptoms was 14.5. The five most prevalent were fatigue, dry mouth, hair loss, drowsiness and lack of appetite. Overall, symptom burden and frequency were higher than in other published MSAS-SF studies. Higher symptom frequency was also found to be significantly related to greater distress in cancer patients undergoing chemotherapy. Conclusions: Patients undergoing chemotherapy suffer from multiple physical and psychological symptoms. Better symptom control or palliative care is needed. Greater frequency of reported symptoms may also indicate a subconscious bid by patients for care and reassurance -thus tailored intervention to manage distress should be offered.

show abstract

Section: Discussionmentioning

confidence: 86%

Symptom Prevalence and Related Distress in Cancer Patients Undergoing Chemotherapy

Thiagarajan

Chan²,

et al. 2016

Asian Pacific Journal of Cancer Prevention

View full text Add to dashboard Cite

show abstract

“…Studies have been small and depression has been conceptualised differently. Still, ESAS has been claimed to be a valid screener (34,35,40).…”

Section: Esas-depression -A Valid Indicator Of Depression?mentioning

confidence: 99%

The Edmonton Symptom Assessment System: Poor performance as screener for major depression in patients with incurable cancer

et al. 2016

View full text Add to dashboard Cite

show abstract

“…Aquellos en que la depresión es conceptualizada como un trastorno psiquiátrico diagnosticado por medio de una entrevista clínica, 6 y 2. los que valoran la presencia o la intensidad de sintomatología depresiva, que contribuye al distrés global del paciente 7 o que consideran la presencia de anhedonia como elemento fundamental. 8 En los estudios en que la depresión se aborda como un trastorno de acuerdo con los criterios del DSM-IV 9 se han reportado rangos de prevalencia que van de 9 a 16%.…”

Section: Definición De Depresión En El Contexto Paliativounclassified

Evaluación de la depresión en pacientes con cáncer terminal y su aplicación en el contexto mexicano: Una revisión

et al. 2014

View full text Add to dashboard Cite

SUMMARYDepression is one of the most common emotional problems in palliative patients. Due to the advanced nature of the disease, several physical symptoms presented by patients overlap with symptoms of depression, making it difficult to evaluate and diagnose the problem. The aim of this paper was to conduct a narrative review of the main instruments used to assess depression when it is present in palliative patients, with a special consideration of the Mexican context. Based on the available data and the scholarly literature, it is more appropriate to conduct an assessment of depression focused on emotional aspects than somatics aspects in palliative patients. Internationally, a number of depression assessments place greater emphasis on anhedonia and emotions, such as hopelessness, than on somatic aspects of depression. In Mexico, a considerable gap remains in the development of instruments to identify depression in the palliative setting. Finally, we describe alternative assessments of depression, which could be evaluated and considered in the future in the palliative care setting.

show abstract

Symptom distress in advanced cancer patients with anxiety and depression in the palliative care setting

Cited by 219 publications

References 44 publications

Symptom Prevalence and Related Distress in Cancer Patients Undergoing Chemotherapy

Symptom Prevalence and Related Distress in Cancer Patients Undergoing Chemotherapy

The Edmonton Symptom Assessment System: Poor performance as screener for major depression in patients with incurable cancer

Evaluación de la depresión en pacientes con cáncer terminal y su aplicación en el contexto mexicano: Una revisión

Contact Info

Product

Resources

About